GLP-1 / GIP / GCGR Tri-Agonist

Retatrutide

Retatrutide dark amber peptide research vial
99.5% Purity
HPLC/MS VerifiedWeight & MetabolicRank #02

Next-generation tri-agonist driving the new wave of metabolic studies.

Retatrutide is an investigational tri-agonist research peptide targeting GLP-1, GIP, and glucagon receptors simultaneously. A leading subject of emerging metabolic literature; available in 5mg and 15mg research-grade lyophilized vials.

Spec

5mg / 15mg - Lyophilized

Mass

5.11-15.08 mg

Purity

99.5%

Mechanism (in vitro)

Triple incretin pathway co-activation; elevated metabolic modulation potential versus dual agonists.

Reconstitution

Reconstitute with 2 mL bacteriostatic water for a 2.5-7.5 mg/mL concentration depending on vial size.

Storage

Store lyophilized at -20 deg C. Reconstituted material is stable at 2-8 deg C for 28 days.

Select SKU

Price · Per Vial

$24.00

5mg

View Cart
Back to Catalog

Research & Operations

Frequently Asked Questions

Clinical-grade answers to the questions that matter most in advanced research procurement.